News Focus
News Focus
icon url

cheynew

12/30/13 7:45 AM

#153674 RE: zare2 #153672

That is waay over the top. No way in h*** that is true.
icon url

PPHMownsME

12/30/13 7:47 AM

#153676 RE: zare2 #153672

You can't be serious.
icon url

horselover45

12/30/13 7:49 AM

#153681 RE: zare2 #153672

Please let's stick to facts.
We really don't need this kind of pumping.
icon url

jimsgtx

12/30/13 7:51 AM

#153682 RE: zare2 #153672

This study is not yet open for participant recruitment... No way they have the majority of the patients enrolled... This just started and the http://clinicaltrials.gov/ct2/show/NCT01999673?term=Bavituximab&rank=8 hasn't changed it yet!
icon url

atonewith PPHM

12/30/13 7:59 AM

#153691 RE: zare2 #153672

Zare, That would be the news to really fire up this baby!! Keeping my fingers crossed.
Atone
icon url

biopharm

12/30/13 8:11 AM

#153698 RE: zare2 #153672

My take is that we already have the majority of the patients enrolled. Can you say hockey stick enrollment?



This I would only think is capable of happening under very, very careful collaboration between our KOL's and the many followers they may have ..... all trickling down to, hopefully many of Peregrines strategically placed clinical sites.

Not saying either way... but the way Peregrine is sticking to their timeline and limiting information due to lawsuits, its possible that the KOL's are playing a role in the recruiting process as well.

There is a reason the new KOL's are here and I can only hope its to reach out to as many as possible (hopefully many responsible for recruiting at the 100+ clinical sites) and since Peregrine has been adhering to their word to a "T" lately...

a hockey stick enrollment just may be coming in the enrollment of this NSCLC Phase III "SunRise" trial.

The facts are the facts--- patients lived "LONGER" than any other NSCLC trial and I think thats the goal for all of us... to live on.

Dr. Philip Thorpe... one more step has been taken!

Phil will be sorely missed as a colleague and friend. At Peregrine, each of us is pursuing Phil's dream of bringing important drugs to patients who need them based on his basic research. We are more motivated than ever to see this dream through.

http://www.peregrineinc.com/about-us/philip-thorpe-ps-targeting-antibody-inventor.html


icon url

DewDiligence

12/30/13 10:17 AM

#153764 RE: zare2 #153672

Enrolling patients before a trial has opened for recruitment would imply that the trial was a hoax, so you might want to rethink your assertion, LOL.